not simply a "cig" company. from SA article awhile ago...please read up:
22nd Century Group (NYSEMKT:XXII) is a small, rather speculative company, but risk and reward go hand in hand here as it's also a company which has really crucial IP that could have a significant impact on the multi-billion dollar tobacco market.
This IP consists of 100+ patents (with new ones added regularly, like here, here and here) that enable the company to regulate the level of nicotine in tobacco, from very high to virtually zero. While there exist chemical ways to reduce nicotine levels, this affects taste, so XXII has a crucial advantage here, cemented by a research licensing deal with British American Tobacco (NYSEMKT:BTI). BAT can exchange this research license into a full commercial license and sub-license (revenues of which will be shared with 22nd Century).
companies sometimes will "rid themselves of debt" to better prop up the balance sheet for acquisition by a suitor...I am holding this view, as the company is much more attractive now, imo. again, just a complete guess...
I never personally bought the $7.50/sh "sale" message...figured it to be an attempt to get another buyer interested. but, that's just me. still believe the sale/breakup to be much greater than the current price.
to hit the hockey stick handle and produce some speedier growth. Good luck to all who decide to hang in there for the long run (up, imo).
also PO'd in Atlanta, as I got interested in Vivus waaaaaaay back in the Muse days...have held on, thinking I would share in the success of Stendra - SINCE IT apparently BEATS VIAGRA & CIALIS & LEVITRA!!!!!! Yet, while the companies who've produced those drugs continue to make MILLIONS UPON MILLIONS, we sit here with an obviously incompetent management who DOES NOT APPEAR TO BELIEVE IN THIS COMPANY any more than the shorts that monopolize this message board! How does a BOARD OF DIRECTORS approve of this management, in light of the fact that VERY LITTLE IS HAPPENING WITH THEIR SUCCESSFUL DRUGS?
mystery to me...
not if a dividend increase comes, or there is more news re: overhead reductions and acquisitions/dispositions. imo, it's about time to begin operating like a REIT, without ops overhead. also, clarification re: GA properties & the $2MM mentioned by another poster that someone's "holding" from ADK (?)...anyone know anymore? hate to see the P get a divvy when we could too...guess you gotta be patient.
did you ever pick up OCLS, or are you over there bashing as well? sorry excuse for a short...loser.
they have a pipeline that goes beyond today's announcement, so I will hold on news from other therapies...this one's not over, imo, and $9-10 is realistic by mid-year, imo, given their clinical focus.
you never answered me...missed OCLS, I see. guess you only troll, don't invest or own anything.
any stock is easy prey for a lonely troll like you today, loser.